Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't

The Waltham startup is taking on the market giant Vertex Pharmaceuticals by developing a pill that targets the 10 percent of patients that Vertex and others haven't touched.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 19, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news